| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 07/06/2006 | US20060148775 E.g., budesonide dodecylcarbonate and budesonide 2-dimethylaminoethyl carbonatewith agonists such as albuterol, formoterol, or salmeterol; used for inducing bronchodilation and treating COPD, asthma and rhinitis. |
| 07/06/2006 | US20060148773 Therapy for hormone sensitive diseases; side effect reduction; anticancer agents; benign prostatic hyperplasa; cardiovascular disorders; acne |
| 06/29/2006 | US20060140816 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 06/27/2006 | US7067682 6,7-Oxygenated steroids and uses related thereto |
| 06/21/2006 | EP1337279B1 Sterilisation of glucocorticosteriode suspensions |
| 06/20/2006 | US7064116 GABAA modulating neurosteroids |
| 06/01/2006 | US20060116418 Materials and methods for treating hypercholesterolemia |
| 05/31/2006 | CN1780849A Process for the production of tibolone |
| 05/25/2006 | US20060111577 Method for preparing 17 alpha-acetoxy-11beta-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
| 05/25/2006 | US20060110771 Proteins capable of binding to female sex hormones and process for producing the same |
| 05/24/2006 | CN1777618A 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos |
| 05/10/2006 | CN1769293A High-purity composition comprising (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one and a process for purifying (7a,17a)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 05/09/2006 | US7041839 Therapy for hormone sensitivity disease; side effect reduction; anticancer agents |
| 05/04/2006 | WO2005115332A3 Heat sterilization of glucocorticosteroids |
| 05/03/2006 | CN1767828A Medicinal composition |
| 05/03/2006 | CN1254479C 3-methylene steroid derivative |
| 04/26/2006 | CN1763066A Methylprednisolone chemical synthesis method |
| 04/26/2006 | CN1763065A Carbon-21 steroidal glycosides possessing immunological suppression action |
| 04/25/2006 | US7033616 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use |
| 04/25/2006 | US7033578 Antimycotic nail varnish composition |
| 04/20/2006 | WO2006041121A1 Remedies/preventives for chronic skin disease |
| 04/20/2006 | CA2584169A1 Remedies/preventives for chronic skin disease |
| 04/19/2006 | CN1252081C Intermediate for preparation of 16 Beta-methyl steroids |
| 04/18/2006 | CA2150738C Process for preparing a 16.beta.-methyl steroid and new intermediates |
| 04/12/2006 | EP1645266A1 Aqueous suspension for nasal drops |
| 03/29/2006 | EP1640009A1 Estrogenic compounds as antimitotic agents |
| 03/28/2006 | US7018995 Carbonate and carbamate modified forms of glucocorticoids |
| 03/23/2006 | US20060063749 immunomoderators ; bromo-3-hydroxyandrostan-17-one; antiallergens; rhinitis |
| 03/23/2006 | US20060063746 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 03/22/2006 | CN1246328C 17 alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 03/14/2006 | US7012070 Estrogenic compounds as anti-mitotic agents |
| 03/08/2006 | EP1240179B1 3-methylene steroid derivatives for the treatment of autoimmune diseases |
| 03/08/2006 | CN1244593C Preparation of fluometasone and its 17-carboxyl androstene analog |
| 02/22/2006 | EP1474435B1 Process for the preparation of 6-alpha fluorinated pregnanes |
| 02/16/2006 | US20060035876 Combination therapy of an SODm and a corticosteroid for prevention and/or treatment of inflammatory bone or joint disease |
| 02/09/2006 | WO2006015081A2 A PROCESS FOR THE PREPARATION OF 7α-ALKYLATED 19-NORSTEROIDS |
| 02/09/2006 | DE102004034008A1 Verfahren zur Herstellung von Albumin-Corticoid-Konjugaten A process for producing corticoid albumin conjugates |
| 02/08/2006 | EP1622924A2 8$g(b)-vinyl-11$g(b)-( g(v)-substituted)alkyl-estra-1,3,5(10)-trienes |
| 02/08/2006 | EP1059977B1 Recovery of organic solutes from aqueous solutions |
| 01/31/2006 | US6992076 Providing sustained systemic concentrations of therapeutic or prophylactic agents such as gamma-aminobutyric acid derivatives following oral adiminstration to animals |
| 01/10/2006 | CA2425841C Angiostatic steroids |
| 12/28/2005 | EP1608670A1 Process for the production of tibolone |
| 12/21/2005 | EP0713393B1 Estrogenic compounds as anti-angiogenesis agents |
| 12/08/2005 | WO2005115332A2 Heat sterilization of glucocorticosteroids |
| 11/30/2005 | EP1599233A2 Sterilization of beclomethasone drug particles for pulmonary delivery |
| 11/29/2005 | US6969708 Process for the preparation of a high purity composition comprising (7α, 17α)- 17-hydroxy- 7-methyl- 19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 11/23/2005 | CN1700920A Phophylactic and therapeutic use of hydroxysteroids |
| 11/22/2005 | US6967195 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent |
| 11/16/2005 | CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases |
| 11/03/2005 | US20050245496 Mixture with carrier; dosage units; prevent ovulation; immonomoderator |
| 10/26/2005 | EP1587818A2 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 10/20/2005 | US20050234017 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 10/20/2005 | US20050234011 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 10/13/2005 | WO2005095434A1 METHOD FOR PRODUCING 5α-PREGNANE DERIVATIVE |
| 10/13/2005 | WO2005095433A1 METHOD FOR PRODUCING 5α-PREGNANE DERIVATIVE |
| 10/13/2005 | WO2005095432A1 METHOD FOR PRODUCING 5α-PREGNANE DERIVATIVE |
| 10/13/2005 | WO2005095431A1 METHOD FOR PRODUCING 5α-PREGNANE DERIVATIVE |
| 10/12/2005 | CN1679472A Antimycotic nail varnish composition |
| 10/06/2005 | US20050222109 Crystalline 19-norsteroids |
| 10/04/2005 | US6951877 Materials and methods for treating hypercholesterolemia |
| 09/28/2005 | CN1674913A Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 09/21/2005 | CN1671858A Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 09/15/2005 | US20050203073 Method of treating inflammatory conditions with progesterone or progesterone analogs |
| 09/14/2005 | CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 08/31/2005 | EP1335928B1 Selective glucocorticoid receptor agonists |
| 08/11/2005 | WO2005044759A3 Acetalization process for preparation of steroid compounds |
| 08/11/2005 | US20050176976 GABA a modulating neurosteroids |
| 08/03/2005 | CN1649602A Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 07/27/2005 | EP1556033A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 06/30/2005 | US20050143365 Structural modification of 19-norprogesterone I: 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
| 06/30/2005 | US20050143364 21-Substituted progesterone derivatives as new antiprogestational agents |
| 06/15/2005 | EP1539182A1 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 06/08/2005 | EP1537068A1 Materials and methods for treating hypercholesterolemia |
| 05/31/2005 | US6900193 Urogential disorders; antitumor agents; hormone inhibitor |
| 05/26/2005 | CA2534342A1 Amino acid prodrugs |
| 05/19/2005 | WO2005044759A2 Acetalization process for preparation of steroid compounds |
| 05/11/2005 | CN1200673C Antimicotic nail varnish composition |
| 04/28/2005 | US20050090675 Oxidation with hydrogen peroxide in basic environment/polar solvent; crystallization; for producing fluticasone propionate |
| 04/28/2005 | US20050090477 Microbiological process for the production of 7-substituted 11-hydroxy steroids, 7,17-substituted 11-halogen steroids that can be produced therefrom, their process for production and use as well as pharmaceutical prepartions that contain these compounds, as well as 7-substituted estra-1,3,5(10)-trienses that can be produced therefrom |
| 04/28/2005 | US20050090476 by protecting the hydroxy group of the steroid with a trialkylsilyl group, then followed a copper mediated 1,6-conjugate addition of a grignard reagent to a 4,6-unsaturated 3-ketosteroid, to yield chemical intermediates used in hormone replacement therapy |
| 04/27/2005 | EP1526139A1 A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters |
| 04/21/2005 | US20050085452 Epoxidation using hydrogen peroxide of 16-dehydropregnanolone acetate ; reduction using hydrazine hydrate; oxidation |
| 04/20/2005 | EP1523568A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 04/19/2005 | US6881728 14-β, 17-α-hydroxymethylandrostane derivatives as androgens |
| 03/29/2005 | CA2100514C 17-spiromethylene steroids |
| 03/24/2005 | US20050065135 Contraceptives; side effect reduction; antitumor, anticancer agents |
| 03/16/2005 | CN1596241A Method for the preparation of 6alpha-fluoro corticosteroids |
| 03/08/2005 | US6863865 Sterilization of pharmaceuticals |
| 03/01/2005 | US6861415 Antagonize endogenous progesterone to induce menses or labor, treat endometriosis, dysmenorrhea; endocrine hormone-dependent tumors, and uterine fibroids, inhibit uterine endometrial proliferation and for contraception |
| 02/24/2005 | WO2004089970A3 Crystalline 19-norsteroids |
| 02/17/2005 | US20050037074 Treating adrenal dysfunction in a patient by administering a pharmaceutically effective amount of a combined glucocorticoid such as hydrocortisone and a delivery vehicle, wherein delivery vehicle provides for delayed and sustained release of glucorticoid; congenital adrenal hyperplasia |
| 02/16/2005 | EP1421099B1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 02/15/2005 | CA2124339C Novel 19-nor steroids having a thiocarbon-containing chain in the 11 beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositionscontaining said steroids |
| 02/10/2005 | US20050032765 Steroid derived antibiotics |
| 02/10/2005 | US20050032760 Continuous process for the production of r-rofleponide |
| 02/03/2005 | US20050026889 Treating acne, seborrhea, hirsutism, alopecia, mastodynia, prostate hyperplasia and carcinoma, virilization syndromes in the female, early puberty, use in inhibition of sexual aggressiveness in the male, male contraception |
| 02/02/2005 | EP1007017B1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof |
| 02/02/2005 | CN1187366C New 19-nor-pregene derivatives |
| 02/02/2005 | CN1187365C Use of 9-alpha-hydroxyl-17-methylene steroids in prepn. of corticosteroids |
| 01/13/2005 | US20050009801 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer. |